Why the study?
Does nesiritide improve urine output and cardiac function in a neonate with heart failure and renal disease?
Does nesiritide improve urine output and cardiac function in a neonate with heart failure and renal disease?
Nesiritide therapy was successfully used to improve urine output and cardiac function in a term neonate with heart failure and renal disease.
Answers are grounded in this paper and cite their sources.
May support nesiritide consideration in neonates with heart failure and renal disease; leaves open confirmation in prospective trials.
A term (39-wk-old) male neonate exhibited respiratory distress and anuria within 2 days of birth. The patient was diagnosed with pulmonary hypertension, polycystic kidney disease, and heart failure; his initial B-type natriuretic peptide concentration was 2460 pg/ml. After minimal response to loop diuretics, the patient was given an infusion of nesiritide 0.01 microg/kg/minute, with no loading dose. Urine output increased over 400%, and cardiac function improved. Nesiritide was titrated to 0.03 microg/kg/minute with no hypotension, decreased renal function, or adverse cardiac sequelae over the next 6 days. No subsequent changes in cardiac function occurred during the infant's stay in a progressive care unit, but he died at age 5.5 months due to sepsis. This case report demonstrates the successful first use of nesiritide therapy in a neonate with renal disease. Further studies are warranted to evaluate the safety and administration of this agent in the neonatal patient population.
No takes yet. Share an insight, caveat, or question.
Moffett et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: